Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)

Abstract Genomic tumor testing (GTT) is an emerging technology aimed at identifying variants in tumors that can be targeted with genomically matched drugs. Due to limited resources, rural patients receiving care in community oncology settings may be less likely to benefit from GTT. We analyzed GTT r...

Full description

Bibliographic Details
Main Authors: Eric C. Anderson, John DiPalazzo, F. Lee Lucas, Michael J. Hall, Andrey Antov, Petra Helbig, Jennifer Bourne, Leah Graham, Lory Gaitor, Christine Lu-Emerson, Leslie S. Bradford, Roger Inhorn, Sarah J. Sinclair, Philip L. Brooks, Christian A. Thomas, Karen Rasmussen, Paul K. J. Han, Edison T. Liu, Jens Rueter
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-024-00547-4

Internet

https://doi.org/10.1038/s41698-024-00547-4

Similar Items